XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities    
Net loss $ (4,977,932) $ (4,506,180)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 159,863 168,440
Loss on disposal of property and equipment 0 6,068
Noncash interest expense 2,087 1,042
Share-based compensation 245,405 261,497
Changes in operating assets and liabilities:    
Accounts receivable 163,174 39,411
Inventory 49,407 (97,849)
Other assets 43,346 199,182
Accounts payable (215,361) (80,276)
Accrued compensation and other liabilities 75,683 211,979
Deferred revenue (6,164) 869
Net cash used in operating activities (4,460,492) (3,795,817)
Cash flows from investing activities    
Purchases of property and equipment (net of proceeds on disposals) (27,022) (1,644)
Net cash used in investing activities (27,022) (1,644)
Cash flows from financing activities    
Proceeds from issuance of common stock, net of issuance costs 2,122,861 0
Proceeds from exercise of stock options and warrants 0 9,271
Payments on debt (25,898) 0
Payments on capital lease obligations (52,706) (63,327)
Net cash provided by/(used in) financing activities 2,044,257 (54,056)
Effects of exchange rates on cash (3,756) 5,254
Net decrease in cash and cash equivalents (2,447,013) (3,846,263)
Cash and cash equivalents at beginning of period 4,117,324 7,814,220
Cash and cash equivalents at end of period 1,670,311 3,967,957
Supplemental disclosure of cash flow information    
Cash paid for interest 10,702 13,021
Supplemental disclosures of noncash investing and financing activities:    
Property and equipment purchased on credit 8,685 27,767
Deferred and accrued financing costs $ 0 $ 52,210